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Abstract
Background: Delirium is a common underdiagnosed condition in advanced cancer leading to increased distress,
morbidity, and mortality. Screening improves detection but there is no consensus as to the best screening tool to
use with patients with advanced cancer.
Objective: To determine the incidence of delirium in patients with advanced cancer within 72 hours of ad-
mission to an acute inpatient hospice using clinical judgement and validated screening tools.
Method: One hundred consecutive patients with advanced cancer were invited to be screened for delirium
within 72 hours of admission to an acute inpatient hospice unit. Two validated tools were used, the Delirium
Rating Scale-Revised 98 (DRS-R-98) and the Confusion Assessment Method (CAM) shortened diagnostic
algorithm. These results were compared with clinical assessment by review of medical charts.
Results: Of 100 consecutive admissions 51 participated and of these 22 (43.1%) screened positive for delirium with
CAM and/or DRS-R-98 compared to 15 (29.4%) by clinical assessment. Eleven (21.6%) were identified as hy-
poactive delirium and 5 (9.8%) as subsyndromal delirium. Conclusion: This study confirms that delirium is a
common condition in patients with advanced cancer.While there remains a lack of consensus regarding the choice of
deliriumscreening tool this study supports theCAMasbeing appropriate. Further researchmaydetermine theoptimal
screening tool for delirium enabling the development of best practice clinical guidelines for routinemedical practice.
Introduction
Delirium is a common,
1–3 serious,4 often under-
recognized5 and undertreated condition in patients with
advanced cancer resulting in increased morbidity and mor-
tality.6,7 It has been estimated that 50% of patients with de-
lirium have a reversible cause8 making early and accurate
diagnosis imperative9 for improving patient outcomes and
the caregiving experience.
The fluctuation and subjectivity of symptoms can make
delirium difficult to recognize, especially the hypoactive–
hypoalert subtype.10 Subsyndromal delirium (SSD) has been
characterized by acute, fluctuating symptoms falling on a
continuum between no delirium and full delirium11 poten-
tially leaving these patients at risk of developing a full syn-
dromal delirium with a poor prognosis.12
While screening improves detection13 there is no consensus as
to the best tool3,14 to use. Most screening tools are promising
with regard to reliability and validity, however, only a small
number are considered to be robust and clinically useable in
palliative care. The tools currently validated for use in palliative
care include the Confusion Assessment Method (CAM) Instru-
ment and its shorter diagnostic algorithm15,16 and the Delirium
Rating Scale and its revised version (DRS and DRS-R-98).17
The purpose of this study was to determine the incidence of
delirium within 72 hours of admission to an acute inpatient
hospice unit, in patients with advanced cancer and to deter-
mine if the use of a validated screening tool increased the
recognition of delirium.
Method
Ethics
Human Research Ethics Approval was obtained for the
study. For the purpose of this study, patients with a known
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preexisting dementia or comorbid psychiatric disorder and
non-English–speaking patients were excluded.
Written information was provided to the patient prior to
obtaining written consent. Where a patient had a cognitive
impairment and was not capable of giving consent, consent
was acquired from either the enduring power of attorney or
the next of kin as identified on admission records.
All positive screens were reported to the treating medical
team so appropriate management could be implemented.
Procedure
Patients over the age of 18 years with a diagnosis of ad-
vanced cancer admitted to a 19-bed acute inpatient specialist
palliative care unit between February 2013 and June 2013
were eligible to participate. Within 72 hours of admission,
100 consecutive patients were invited to be screened using
the DRS-R-98 and the shortened CAM. The investigator,
who had extensive clinician experience including mental
health skills training, was not the admitting officer or a
member of the treating team.
On completion of screening, patient electronic medical re-
cordswere audited to determine if the treatingmedical teamhad
recognized and documented the presence of delirium. These
records contained medical history and physical examination
findings, nursing assessments, and multidisciplinary team
progress notes. The criteria used to recognize delirium was a
written diagnosis of ‘‘delirium’’ or symptoms listed that cor-
related to Diagnostic and Statistical Manual of Mental Dis-
orders, FourthEdition, Text revision (DSM-IV-TR)18 guidelines,
e.g., acute confusion within 72 hours of admission or if a pre-
scription of the antipsychotic haloperidol (drug of first choice)
or olanzapine were prescribed where it was known these drugs
were not prescribed for other reasons. Data regarding demo-
graphic elements, primary diagnosis, performance status, and
disease trajectory phase were collected for each patient.
Screening tools
The DRS-R-98 is a 16-item tool with a maximum total score
of 46. For a diagnosis of delirium the 3 diagnostic items (14–16)
must be satisfied and, as recommended by the original valida-
tion study, a severity score of 15 ormore or a total score of 18 or
more (92% sensitivity and 93% specificity) is required,17 al-
though a total score of 13 or more11,19 has been suggested. For
the purpose of this study the lower cutoff has been used to allow
for detection of SSD using a total score of 8–13.11,20
Shortened CAM is a brief (less than 5 minutes) observa-
tional tool (94%–100% sensitivity and 90–95% specificity15)
consisting of four questions that can be completed by the
patient, carer or staff. For a diagnosis of delirium, features 1
(acute onset and fluctuating course) and 2 (inattention) must
be present along with either feature 3 (disorganized thinking)
or 4 (altered level of consciousness).
Statistical analysis
Data were analyzed using SPSS-20 (SPSS Inc., Armonk,
NY). Descriptive statistics were used to report the percentage
of patients whose assessments indicated the presence of de-
lirium and the demographic characteristics of participants. v2
analysis was used to examine differences in gender, diagnosis
and reason for admission between patients presenting with
delirium and those who did not.
Results
The use of one researcher increased consistency in applying
the tool, however, it was not possible to access all admissions
within 72 hours. Of the 100 consecutive admissions 51 patients
were screened, 9 refused, and 40 were excluded including 10
patients considered ‘‘too unwell’’ to be approached based on
the clinical judgement of either the treating team or investi-
gator (Table 1). In comparison, 9 patients who refused did so
for a variety of reasons such as ‘‘I’m not interested,’’ ‘‘I’m too
tired,’’ or ‘‘I’m not confused.’’
Of the 51 patients screened 22 (43.1%) met the criteria for
delirium on the DRS-R-98 and/or CAM with 20 (39.2%)
patients recording a positive result on both tools. Five (9.8%)
patients fulfilled the criteria for subsyndromal delirium
having symptoms less severe than those with full delirium.
No significant differences in gender, diagnosis or reason for
admission were found between those who screened positively
for delirium and those who did not. Clinical and demographic
characteristics are shown in Table 2 and comparative results
of the different screening methods in Table 3.
To fulfill the diagnostic criteria of delirium all patients
with a positive result on the CAM had acute and fluctuating
changes in mental status and difficulty focusing attention.
Twelve patients (57.1%) had disorganized or incoherent
thinking and 17 (81%) had altered levels of consciousness.
Among the various symptoms present, all patients with full
or subsyndromal delirium on DRS-R-98 had acute and fluc-
tuating symptoms including similar severity of sleep-wake
cycle disturbance (60% had a severity score ‡ 2). Ninety-five
percent of patients with full delirium had disturbances in
attention compared to 60% with subsyndromal delirium.
Other common symptoms seen in full delirium compared to
subsyndromal included disturbances in thought processes
(76.2% versus 20%), delusions and hallucinations (59.5%
versus 30%), and memory disturbance (64.25% versus 20%).
Where symptoms were present, the severity in the SSD group
was consistently less than in full delirium.
Of the 21 patients with a positive DRS-R-98 result based on
motor agitation/retardation, 11 (52.4%) were classified as hav-
ing hypoactive delirium and 3 (14.3%) with hyperactive sub-
type. The treating team recognized delirium in 15 (29.4%)
patients, including all 3with hyperactive delirium and 6 (54.5%)
with hypoactive delirium but none with subsyndromal delirium.
Two patients with discordant CAM and DRS-R-98 results
demonstrated acute and fluctuating changes in mental status.
The patient with a positive CAM and negative DRS-R-98
(score of 12) had verymild symptoms suggesting subsyndromal
Table 1. Reasons for Nonparticipation
in Delirium Screening
Reason for not participating n= 49 %
Too unwella 10 20.4
Refusedb 9 18.4
Unresponsive 9 18.4
Exceeded 72-hour limit 9 18.4
Died/discharge before screened 5 10.2
Dementia 4 8.1
Non-English speaking 3 6.1
aDecision made by nursing or medical teams.
bDecision made by patient or proxy.
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delirium. The other patient, with a positive DRS-R-98 (score of
13) and negative CAM reported hallucinations and delusions,
sleep disturbance, and lability of affect but on screening was
alert and displayed no problems focusing attention.
On occasions when screening was positive in the absence of
a documented medical diagnosis one patient was noted to be
‘‘alert and orientated,’’ another ‘‘drowsy.’’ A third patient was
identified to the medical team as having a positive result.
Subsequent review of medical notes showed a night nursing
entry as ‘‘confused overnight.’’ Hewas subsequently diagnosed
with hypercalcemia. In this case the screening test detected an
evolving deliriumbefore it was recognized by the treating team.
Families of three unresponsive patients consented to par-
ticipate and while the DRS-R-98 was not used, completion of
the CAM and medical record audit showed a positive result
for delirium in the preceding 24 hours. These data were ex-
cluded from the final analysis because it was incomplete.
Discussion
Delirium is a common condition in patients with advanced
cancer and the results of this study were consistent with the
literature.3 In this study, based on clinical judgment alone the
incidence of delirium on admission to the hospice was 29.4%
increasing to 43.1% when a validated screening tool was
applied. The clinical recognition rate is consistent with a
previous audit of 94 medical charts undertaken in 2012 in the
same setting using the same criteria in which 29 (30.9%)
patients were found to have a clinical diagnosis of delirium.
Results demonstrated the treating team recognized all pa-
tients with hyperactive delirium, however, they failed to
recognize 45.5% of those with hypoactive subtype and all
with subsyndromal delirium. These results reflect current
practice of palliative care clinicians in this setting with re-
spect to delirium diagnosis and support the view that delir-
ium, in particular hypoactive delirium, is often missed or
mistaken for other conditions especially depression.
The DRS-R-98 was chosen for its ability to classify the
severity and subtypes of delirium when screening patients.
However, there were a number of difficulties using the DRS-
R-98 resulting in incomplete data collection. Two patients
were partially blind and immobile, preventing the assessment
of visuospatial ability. This did not affect one patient’s score,
however, the other patient’s score was borderline, demon-
strating inconsistencies in assessment.
Table 2. Demographic Characteristics
of Screened Patients
Demographic
Delirium
detected
Delirium
absent
n = 22 n = 29
Age Mean= 70.1years
(SD,13.8; range,
32–89years)
Mean= 71.3years
(SD,13.9;range,
44–92years)
Gender
Female 13 (59.1%) 19 (65.5%)
Male 9 (40.9%) 10 (34.5%)
Cancer diagnosis
Breast 6 (27.3%) 5 (17.2%)
Lung 4 (18.2%) 2 (6.9%)
Gynecologic 3 (13.7%) 2 (6.9%)
Colorectal 1 (4.5%) 6 (20.7%)
Other GIT 3 (13.7%) 7 (24.1%)
Head and neck 1 (4.5%) 2 (6.9%)
Brain (GBM) 2 (9.1%) 2 (6.9%)
Prostate 1 (4.5%) —
Melanoma 1 (4.5%) —
Hematologic — 2 (6.9%)
Neuroendocrine — 1 (3.5%)
Brain metastases
Present 6 (27.3%) 2 (6.9%)
Reason for admission
End-of-life care 9 (40.9%) 10 (34.5%)
Symptom
management
13 (59.1%) 15 (51.7%)
Respite — 4 (13.8%)
Disease trajectory
Stable 1 (4.5%) 11 (37.9%)
Unstable 8 (36.4%) 11 (37.9%)
Deteriorating 11 (50%) 4 (13.8%)
Terminal 2 (9.1%) 3 (10.4%)
Pain score/10 Mean = 3.4
(SD, 2.5;
range, 0–8)
Mean = 3.3
(SD, 2.6;
range, 0–10)
Australian modified
Karnofsky
Performance Score
Mean = 35.9
(SD, 10.9;
range, 20–60)
Mean = 42.4
(SD, 12.4;
range, 20–70)
SD, standard deviation; GIT, gastrointestinal tract; GBM, glio-
blastoma multiforme.
Table 3. Comparative Results of Screening Methods
n = 51 DRS-98-R CAMa Clinical
Positive
screen
21 (41.2%) 21 (41.2%) 15 (29.4%)
Mean score: 17.64
SD, 3.8; range,
13–27.5
Negative
screen
30 (58.8%) 36 (70.6%) 30 (58.8%)
Mean score: 3.9
SD, 3.6; range,
0–12
SSDb 5 (9.8%)
Mean score: 10.6 1/5
detected
0/5
recognized
SD, 1.95; range,
8–12
Hyperactive
deliriumb
3 (5.9%)
Mean score:24.7 3/3
detected
3/3
recognized
SD, 3.3; range,
21–27.5
Hypoactive
deliriumb
11 (21.6%)
Mean score 16.9 11/11
detected
6/11
recognized
SD, 2.5; range,
13–21
aCAM results only indicate the presence or absence of delirium.
bDetected by DRS-R-98.
DRS-98-R, Delirium Rating Scale-Revised 98; CAM, Confusion
Assessment Method; SD, standard deviation; SSD, subsyndromal
delirium.
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The DRS-R-98 as a screening tool did classify most patients
(66.7%) into hyperactive or hypoactive subtype, however, it
was limited by its complexity and time taken to complete
adding to the burden of care, without any screening benefit. In
contrast, the brevity of the CAM enhanced its utility as a
screening tool and while there was an element of subjectivity
in the assessment scoring the data collected indicated it to be
equally reliable in detecting both florid hyperactive delirium
and hypoactive delirium in the quiet, sleepy, compliant patient.
While clinical judgment in this setting is sound, screening
was clinically relevant for individual patients as it resulted in
a change in management plans as demonstrated by the cases
of discrepancy between screening results and documentation.
The literature suggests the incidence of delirium is highest
in the terminal phase of illness8 but consent to screen these
frail patients was often withheld. This limitation, along with
small sample size and a single center study, hampers the
generalizability of results as the participants were not nec-
essarily representative of all patients with advanced cancer
admitted to inpatient hospice settings. Future studies on de-
lirium may benefit from integrating screening into standard
practice to avert any issues of gatekeeping.
In conclusion, this study confirms that delirium is a com-
mon condition in patients with advanced cancer. While a lack
of consensus regarding the choice of delirium screening tool
remains, this study supports the CAM as being appropriate.
However, while screening is helpful, the results must be in-
terpreted within a clinical context and screening tools should
always complement clinical judgment rather than replace it.
Further research may determine the optimal screening tool
for delirium enabling the development of best practice clin-
ical guidelines for routine medical practice.
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